Guidance

List of approved countries for authorised human medicines if there is a no-deal Brexit

Approved countries for batch testing and importation of medicines if there is a no-deal Brexit

Documents

Details

Stay up to date

The UK is leaving the EU. This page tells you how to prepare for Brexit and will be updated if anything changes.

Sign up for email alerts to get the latest information.

If the UK leaves the EU without a deal, the Human Medicines Regulations 2012 will refer to lists of approved countries for:

  • Importation of medicines under a wholesale dealer’s licence
  • Batch testing of medicines
  • Manufacturing of active substances with regulatory standards equivalent to the UK

The list of approved countries will enable UK importers and wholesalers to continue to recognise batch testing, QP certification and regulatory standards for active substance manufacture performed in certain countries in the same way as before exit day.

This guidance provides the lists of countries and a summary of the circumstances under which the lists can be used.

This guidance will apply from exit day in line with the Human Medicines Regulations (Amendment etc.) (EU Exit) Regulations 2019.

Published 11 March 2019
Last updated 9 October 2019 + show all updates
  1. Change of text within Stay up to date box.
  2. Following the EU now recognising batch testing from the USA, we have edited section 3.3. to reflect which classes of medicines remain excluded. We also removed some outdated background information.
  3. First published.